Circadian variations in cytokines and the effect of timed release tablet prednisone in rheumatoid arthritis

Trial Profile

Circadian variations in cytokines and the effect of timed release tablet prednisone in rheumatoid arthritis

Completed
Phase of Trial: Phase II

Latest Information Update: 19 Jan 2012

At a glance

  • Drugs Prednisone (Primary)
  • Indications Rheumatoid arthritis
  • Focus Pharmacodynamics
  • Most Recent Events

    • 19 Jan 2012 Actual end date (Jun 2008) added as reported by ISRCTN: Current Controlled Trials.
    • 19 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ISRCTN: Current Controlled Trials.
    • 22 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top